Delivery Order SPE2DB22D2006-SPE2DB24FW2MN

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,304.87, is a firm fixed-price delivery order for the supply of 4565331970 - Methylergonovine 0.2 mg/ml vial. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.44 firm fixed-price contract is for the delivery of 4557734719 methylergonovine 0.2 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,794.96 contract is for the delivery of the drug methylergonovine 0.2 mg/ml to support military treatment programs and facilities. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to...
This $1,270.65 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566477281 METHYLERGONOVINE 0.2 MG/ML VLML, with a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide METHYLERGONOVINE 0.2 MG/ML VLML, a specialty pharmaceutical product, with a potential value of $5,126.30. The delivery order has a completion date of February 12, 2024 and does not fall under any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC)...
This federal contract award, valued at $1,794.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of 4565019375 - Methylergonovine 0.2 mg/ml VLML, a pharmaceutical product, with a completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg tablets, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price of $1,208.02 and a period of performance through April 11, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug...
This federal contract award, valued at $2,991.60, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of METHYLERGONOVINE 0.2 MG/ML VLML, with a performance period ending on June 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565213357 Methyldopa 250 mg tablets in 90-count packages. The contract has a firm fixed price of $1,128.47 and a period of performance through July 22, 2024. It is not a set-aside contract. As a large pharmaceutical vendor, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2MN
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,467.96, is for the supply of the pharmaceutical product methylergonovine 0.2 mg/ml ampoules. The contract does not have a set-aside designation and has a period of performance through August 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, vaccines, and medical supplies, to support various government healthcare programs and military treatment facilities nationwide. The company holds several Indefinite Delivery Contracts (IDCs) with agencies like the DLA and the Department of Justice, enabling efficient procurement of these critical pharmaceutical and medical products.

Generated 11/4/24, 11:32 AM